IL122386A0 - Anti-fungal and anti-bacterial histatin-based peptides - Google Patents

Anti-fungal and anti-bacterial histatin-based peptides

Info

Publication number
IL122386A0
IL122386A0 IL12238696A IL12238696A IL122386A0 IL 122386 A0 IL122386 A0 IL 122386A0 IL 12238696 A IL12238696 A IL 12238696A IL 12238696 A IL12238696 A IL 12238696A IL 122386 A0 IL122386 A0 IL 122386A0
Authority
IL
Israel
Prior art keywords
fungal
based peptides
histatin
bacterial
naturally occurring
Prior art date
Application number
IL12238696A
Other languages
English (en)
Original Assignee
Periodontix Inc
Univ Boston
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Periodontix Inc, Univ Boston filed Critical Periodontix Inc
Publication of IL122386A0 publication Critical patent/IL122386A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
IL12238696A 1995-06-07 1996-06-07 Anti-fungal and anti-bacterial histatin-based peptides IL122386A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/481,888 US5631228A (en) 1991-11-01 1995-06-07 Anti-fungal and anti-bacterial histatin-based peptides

Publications (1)

Publication Number Publication Date
IL122386A0 true IL122386A0 (en) 1998-06-15

Family

ID=23913789

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12238696A IL122386A0 (en) 1995-06-07 1996-06-07 Anti-fungal and anti-bacterial histatin-based peptides

Country Status (11)

Country Link
US (1) US5631228A (de)
EP (1) EP0832119B1 (de)
JP (1) JPH11508238A (de)
AT (1) ATE196475T1 (de)
AU (1) AU709204B2 (de)
CA (1) CA2223505C (de)
DE (1) DE69610424T2 (de)
DK (1) DK0832119T3 (de)
ES (1) ES2151172T3 (de)
IL (1) IL122386A0 (de)
WO (1) WO1996040768A2 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025326A (en) * 1995-07-07 2000-02-15 Intrabiotics Pharmaceuticals, Inc. Compositions and methods for the prevention and treatment of oral mucositis
CA2236223C (en) * 1995-11-03 2002-08-06 Unilever Plc Natural composition for combatting fungi
US6531573B1 (en) 1997-12-18 2003-03-11 Trustees Of Boston University Antifungal and antibacterial peptides
NL1008745C2 (nl) * 1998-03-30 1999-10-01 Stichting Tech Wetenschapp Therapeutisch werkzame verbinding voor behandeling van gist- en/of schimmelinfecties in de mondholte.
GB9818938D0 (en) 1998-08-28 1998-10-21 Alpharma As Bioactive peptides
US8283315B2 (en) 1998-08-28 2012-10-09 Lytix Biopharma As Inhibition of tumour growth
US6528488B2 (en) * 1999-01-08 2003-03-04 Demegen, Inc. Method for treating cystic fibrosis
US6800291B1 (en) * 1999-03-24 2004-10-05 Zengen, Inc. Uro-genital condition treatment system
US6833435B2 (en) * 1999-08-23 2004-12-21 Matthew Glenn Compositions isolated from bovine tissues and methods for their use
US7592304B2 (en) * 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7632803B2 (en) 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US20030158111A1 (en) * 1999-10-01 2003-08-21 David Bar-Or Methods and products for oral care
CA2285673C (en) 1999-10-21 2008-07-29 Gilles Andre Lajoie Cyclic analogs of histatins
BR0111718A (pt) 2000-06-16 2003-09-09 Hercules Inc Peptìdeos quimicamente modificados, composições e métodos de produção e uso
US6576226B1 (en) * 2000-11-17 2003-06-10 Gary R. Jernberg Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
US6726898B2 (en) 2000-11-17 2004-04-27 Gary R. Jernberg Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
US7090497B1 (en) 2001-02-21 2006-08-15 Harris David M Method of periodontal laser treatment
US20040127892A1 (en) * 2002-01-31 2004-07-01 Harris David M. Periodontal laser and methods
US7033769B2 (en) 2002-05-23 2006-04-25 The United States Of America As Represented By The Secretary Of The Army Method for discovering one or more peptides adapted for specific binding to a microorganism of interest
US7087228B2 (en) * 2002-07-03 2006-08-08 University Of Southern California Preventing tooth decay and infective endocarditis using natural oligopeptides
EP1616035A4 (de) * 2003-04-01 2007-02-21 Univ Southern California Kariesrisikotest zur vorhersage und beurteilung des risikos einer erkrankung
US9127045B2 (en) * 2005-11-17 2015-09-08 University Of Southern California Method of inhibiting bacterial growth and biofilm formation with natural quorum sensing peptides
WO2009005798A2 (en) * 2007-07-03 2009-01-08 Pacgen Biopharmaceuticals Corporation Antifungal formulation and method of preparation
US9090670B2 (en) 2008-01-07 2015-07-28 Rapid Pathogen Screening, Inc. Use of peptides for promoting wound healing
CA2710822C (en) 2008-01-07 2022-06-14 Johannes Gerhardus Maria Bolscher Use of histatin derived peptides for promoting wound healing
US20100047734A1 (en) * 2008-08-20 2010-02-25 PathoLase, Inc. Periodontal laser treatment and laser applicator
BR112012020753A2 (pt) * 2010-02-19 2016-05-03 Univ O South Dakota prótese dentária antimicrobiana, e, método para reduzir uma infecção fúngica
US20130310327A1 (en) * 2012-05-18 2013-11-21 Rapid Pathogen Screening, Inc. Histatin for Corneal Wound Healing and Ocular Surface Disease
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US20170022256A1 (en) * 2015-07-23 2017-01-26 General Biologicals Corporation Anti-fungal and anti-bacterial peptide and therapeutic method using same
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
EP4294825A1 (de) * 2021-02-16 2023-12-27 The University of Hong Kong Antibakterielle und mineralisierende zusammensetzungen und verfahren zur verwendung davon

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725576A (en) * 1983-12-29 1988-02-16 Research Foundation Of State University Of New York Fungicidal polypeptide compositions containing L-histidine and methods for use therefore
US5032574A (en) * 1988-05-26 1991-07-16 Invitron Corporation Novel antimicrobial peptide
US5221732A (en) * 1988-12-06 1993-06-22 The United States Of America As Represented By The Department Of Health And Human Services Antimicrobial magainin modified peptides
JP2818056B2 (ja) * 1990-09-07 1998-10-30 森永乳業株式会社 抗菌性ペプチドおよび抗菌剤
US5225399A (en) * 1991-04-15 1993-07-06 The Children's Hospital Of Philadelphia Antimicrobial amphiphilic peptides
US5239059A (en) * 1991-05-10 1993-08-24 The Children's Hospital Of Philadelphia Ion-channel forming peptides
US5324716A (en) * 1991-06-14 1994-06-28 Regents Of The University Of California Broad spectrum antimicrobial compounds and methods of use
US5486503A (en) * 1991-11-01 1996-01-23 The Trustees Of Boston University Anti-fungal histatin-based peptides
JPH06234653A (ja) * 1993-02-10 1994-08-23 Sunstar Inc 歯周組織再生促進剤および材料
US5459235A (en) * 1993-03-19 1995-10-17 The Regents Of The University Of California Antimicrobial peptides antibodies and nucleic acid molecules from bovine neutrophils
JPH06287146A (ja) * 1993-03-31 1994-10-11 Sunstar Inc 皮膚外用剤

Also Published As

Publication number Publication date
DE69610424T2 (de) 2001-01-25
WO1996040768A3 (en) 1997-03-06
US5631228A (en) 1997-05-20
WO1996040768A2 (en) 1996-12-19
CA2223505C (en) 2003-10-14
DE69610424D1 (de) 2000-10-26
ATE196475T1 (de) 2000-10-15
AU709204B2 (en) 1999-08-26
EP0832119B1 (de) 2000-09-20
JPH11508238A (ja) 1999-07-21
ES2151172T3 (es) 2000-12-16
AU6158596A (en) 1996-12-30
EP0832119A2 (de) 1998-04-01
DK0832119T3 (da) 2000-11-20
CA2223505A1 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
IL122386A0 (en) Anti-fungal and anti-bacterial histatin-based peptides
IL122387A0 (en) Anti-fungal d-amino acid histatin-based peptides
AU1879697A (en) Peptide immunogens for vaccination against and treatment of allergy
EP0859627A4 (de) Peptid-immitierende substanzen in der krebstherapie
ATE198050T1 (de) Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia
AU1679795A (en) Anti-fungal methods and materials
MX9710252A (es) Utilizacion de al menos un peptido en una composicion cosmetica o para la preparacion de un medicamento.
AU3909497A (en) Anti-chlamydial methods and materials
EP0813544A4 (de)
DE69530844D1 (de) Verfahren und substanzen gegen protozoen
EP0869801A4 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
GR3035152T3 (en) Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/tyrosinase peptide antigens
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
AU1278600A (en) Novel therapeutic application of nicergoline
AU9017298A (en) Reptilian-derived peptides for the treatment of microbial infection
AU7728296A (en) Hemoregulatory compounds
AU3084297A (en) Novel peptides for prevention and treatment of infection
ZA975500B (en) Peptides for prevention and treatment of infection